The outcomes of secondary AML post allogeneic hematopoietic cell transplantation significantly depend on the presence of poor‐risk cytogenetic abnormalities

Abstract Secondary acute myeloid leukemia (sAML) includes AML as a complication of an antecedent hematological disorder or a therapy‐related AML. Large registry‐based data identified sAML as an independent poor‐outcome type of AML post allogeneic hematopoietic cell transplantation (allo‐HCT). In our...

Full description

Bibliographic Details
Main Authors: Mona Hassanein, Riad El Fakih, Walid Rasheed, Syed Ahmed, Marwan Shaheen, Naeem Chaudhri, Fahad Alsharif, Shad Ahmed, Amr Hanbali, Alfadel AlShaibani, Feras Alfraih, Saud Alhayli, Tusneem Elhassan, Ali Alahmari, Hazzaa Alzahrani, Fahad Almohareb, Mahmoud Aljurf, Shahrukh Hashmi
Format: Article
Language:English
Published: Wiley 2021-05-01
Series:eJHaem
Online Access:https://doi.org/10.1002/jha2.136